United States Guidelines on Dyslipidemia. Strengths and Weaknesses

Juan Pedro-Botet, Juan J. Chillarón, David Benaiges, Juana A. Flores Le-Roux

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


© 2015 Sociedad Española de Cardiología. The American College of Cardiology and the American Heart Association have produced new guidelines on cholesterol levels and the risk of atherosclerotic cardiovascular disease that represent a paradigm shift in the treatment of hypercholesterolemia because they abandon the use of the low-density lipoprotein cholesterol level as the therapeutic target and focus instead on the clinical benefits of statins. This article presents the key features of these guidelines and highlights both their strengths and areas open to improvement.
Original languageEnglish
Pages (from-to)18-21
JournalRevista Espanola de Cardiologia Suplementos
Issue numberS1
Publication statusPublished - 1 Jan 2015


  • Cardiovascular disease
  • Cardiovascular risk
  • Cholesterol
  • Clinical guidelines
  • Statins


Dive into the research topics of 'United States Guidelines on Dyslipidemia. Strengths and Weaknesses'. Together they form a unique fingerprint.

Cite this